(Q28290823)

English

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

scientific article

Statements

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study (English)
0 references
0 references
Benjamin M Segal
0 references
Aparna Raychaudhuri
0 references
Lilianne Kim
0 references
Rosanne Fidelus-Gort
0 references
Lloyd H Kasper
0 references
September 2008
0 references
7
0 references
796-804
0 references
9
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit